{"id":1917,"date":"2024-05-25T18:32:33","date_gmt":"2024-05-25T21:32:33","guid":{"rendered":"https:\/\/www.cimmdp.com.ar\/?page_id=1917"},"modified":"2026-06-05T11:26:18","modified_gmt":"2026-06-05T14:26:18","slug":"patrocinadores","status":"publish","type":"page","link":"https:\/\/www.cimmdp.com.ar\/en\/sponsors\/","title":{"rendered":"Sponsors"},"content":{"rendered":"<div data-elementor-type=\"wp-page\" data-elementor-id=\"1917\" class=\"elementor elementor-1917\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7a55132 e-flex e-con-boxed e-con e-parent\" data-id=\"7a55132\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-44c6db7 protaccordeon elementor-widget elementor-widget-n-accordion\" data-id=\"44c6db7\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;default_state&quot;:&quot;expanded&quot;,&quot;max_items_expended&quot;:&quot;one&quot;,&quot;n_accordion_animation_duration&quot;:{&quot;unit&quot;:&quot;ms&quot;,&quot;size&quot;:400,&quot;sizes&quot;:[]}}\" data-widget_type=\"nested-accordion.default\">\n\t\t\t\t\t\t\t<div class=\"e-n-accordion\" aria-label=\"Accordion. Open links with Enter or Space, close with Escape, and navigate with Arrow Keys\">\n\t\t\t\t\t\t<details id=\"e-n-accordion-item-7210\" class=\"e-n-accordion-item\" open>\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"1\" tabindex=\"0\" aria-expanded=\"true\" aria-controls=\"e-n-accordion-item-7210\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> Therapeutic areas and Protocols <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-7210\" class=\"elementor-element elementor-element-8235b42 e-con-full e-flex e-con e-child\" data-id=\"8235b42\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-f713298 elementor-widget elementor-widget-template\" data-id=\"f713298\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"template.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-template\">\n\t\t\t\t\t<div data-elementor-type=\"section\" data-elementor-id=\"1973\" class=\"elementor elementor-1973\" data-elementor-post-type=\"elementor_library\">\n\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-7210\" class=\"elementor-element elementor-element-6a9273c e-flex e-con-boxed e-con e-parent\" data-id=\"6a9273c\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-09b155b elementor-widget elementor-widget-shortcode\" data-id=\"09b155b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"shortcode.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-shortcode\"><div id=\"protresume\"><div class=\"item\"><h2>Cardiology<\/h2><a href=\"#mdla14\" rel=\"modal:open\"><button data-id=\"14\" class=\"btn active\">Active Studies<\/button><\/a><a href=\"#mdli14\" rel=\"modal:open\"><button data-id=\"14\" class=\"btn inactive\">Completed Studies<\/button><\/a><div id=\"mdla14\" class=\"modal pcnt act14\" style=\"display:none;\"><h2>Active Studies - Cardiology<\/h2><p><b>EASi-HF Reduced<\/b><br>T\u00edtulo del protocolo: EASi-HF Reduced: ensayo de superioridad de fase III, doble ciego, aleatorizado y de grupos paralelos para evaluar la eficacia y la seguridad del uso combinado de BI 690517 oral y empagliflozina en comparaci\u00f3n con placebo y empagliflozina en participantes con insuficiencia card\u00edaca cr\u00f3nica sintom\u00e1tica (IC: NYHA II-IV) y fracci\u00f3n de eyecci\u00f3n del ventr\u00edculo izquierdo (FEVI) &lt; 40 %<br><br><b>EASi-HF<\/b><br>\u201cUn ensayo de superioridad de grupos paralelos, aleatorizado, doble ciego de fase III para evaluar la eficacia y seguridad del uso combinado de BI 690517 oral y empagliflozina en comparaci\u00f3n con placebo y empagliflozina en pacientes con insuficiencia card\u00edaca (IC)  clases II a IV) y fracci\u00f3n de eyecci\u00f3n del ventr\u00edculo izquierdo (FEVI) &gt;=40%\u201d.<br><br><\/p><\/div><div id=\"mdli14\" class=\"modal pcnt ina14\" style=\"display:none;\"><h2 class=\"fn\">Completed Studies - Cardiology<\/h2><p><b>BaxHTN<\/b><br>A randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of Baxdrostat in participants with uncontrolled hypertension taking two or more medications, including participants with resistant hypertension.<br><br><b>LIBREXIA ACS<\/b><br>A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Event-Based Study to Demonstrate the Efficacy and Safety of an Oral Factor XIa Inhibitor, Following Recent Acute Coronary Syndrome (ACS)<br><br><b>HERMES<\/b><br>Effects of ziltivekimab versus placebo on morbidity and mortality in patients with chronic heart failure with preserved ejection fraction and systemic inflammation.<br><br><b>LIBREXIA AFL<\/b><br>A Phase 3, randomized, double-blind, double-dummy, parallel-group, active study to evaluate the efficacy and safety of Milvexian, an oral factor XIa Inhibitor, versus apixaban in participants with atrial fibrillation.<br><br><b>AMETHYST<\/b><br>AMETHYST - D5496C00005\n\"A Phase 2, multicenter, double-blind, 3-arm, placebo- and active-controlled study to evaluate the efficacy and safety of Verinurad combined with allopurinol in heart failure with preserved ejection fraction.\"<br><br><b>NODE-303<\/b><br>Multicenter, multinational, open-label study to evaluate the safety of etripamil nasal spray in patients with paroxysmal supraventricular tachycardia. Phase III<br><br><b>AUGUSTUS<\/b><br>CV185316 Open-label, 2x2 factorial, randomized, controlled clinical trial to evaluate the safety of Apixaban compared to a vitamin K antagonist and aspirin compared to aspirin placebo in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention.<br><br><b>MARINER<\/b><br>RIVAROXDVT3002; Phase 3 BAY 59-7939\/17261\nEvaluation, in patients with medical conditions, of rivaroxaban versus placebo in reducing the risk of venous thromboembolism after hospital discharge\n(MARINER)<br><br><\/p><\/div><\/div><div class=\"item\"><h2>Cardiometabolico<\/h2><a href=\"#mdla15\" rel=\"modal:open\"><button data-id=\"15\" class=\"btn active\">Active Studies<\/button><\/a><a href=\"#mdli15\" rel=\"modal:open\"><button data-id=\"15\" class=\"btn inactive\">Completed Studies<\/button><\/a><div id=\"mdla15\" class=\"modal pcnt act15\" style=\"display:none;\"><h2>Estudios Activos - Cardiometabolico<\/h2><p><b>ATTAIN<\/b><br>T\u00edtulo del protocolo: Estudio de fase 3, aleatorizado, doble ciego, controlado con placebo y basado en eventos para investigar el efecto de orforglipron en la incidencia de eventos cardiovasculares adversos mayores en participantes con enfermedad cardiovascular ateroscler\u00f3tica establecida o enfermedad renal cr\u00f3nica (ATTAIN-Outcomes)<br><br><b>Enith 2<\/b><br>WC45726 (0165\/1298): \r\nESTUDIO DE FASE 3, ALEATORIZADO, DOBLE CIEGO, ESTUDIO GRUPAL CONTROLADO CON PLACEBO, PARALELO\r\nESTUDIO GRUPAL PARA EVALUAR LA EFICACIA Y SEGURIDAD DE LA ADMINISTRACI\u00d3N SEMANAL DE RO7795068 (CT RO7795068 (CT-388) -388) ADMINISTRADO A PARTICIPANTES CON OBESIDAD O SOBREPESO Y DIABETES TIPO 2.<br><br><b>Enith 1<\/b><br>WC45725 (0165\/1297): \r\nESTUDIO DE FASE 3, ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO, PARALELO.\r\nESTUDIO DE GRUPO PARA EVALUAR LA EFICACIA Y SEGURIDAD DE LA ADMINISTRACI\u00d3N SEMANAL DE UNA VEZ RO7795068 (CT RO7795068 (CT-388) -388) ADMINISTRADO A PARTICIPANTES CON OBESIDAD O SOBREPESO SIN DIABETES TIPO 2<br><br><b>J2O-MC-EKBG<\/b><br>Estudio de fase 3, aleatorizado, doble ciego y controlado con placebo para investigar el efecto de Muvalaplin en la reducci\u00f3n de eventos cardiovasculares adversos mayores en adultos con lipoprote\u00edna(a) elevada que han tenido un evento cardiovascular ateroscler\u00f3tico previo o est\u00e1n en riesgo de sufrir un primer evento cardiovascular ateroscler\u00f3tico - MOVE-Lp(a)<br><br><b>MARITIME &#8211; CV<\/b><br>Un estudio de fase 3, aleatorizado, doble ciego y controlado con placebo para evaluar el impacto de Maridebart Cafraglutide en los resultados cardiovasculares en participantes que viven con sobrepeso u obesidad y enfermedad cardiovascular ateroscler\u00f3tica.<br><br><b>BaxDuo PREVENT HF<\/b><br>Estudio de fase III para investigar el riesgo de insuficiencia card\u00edaca y muerte cardiovascular con Baxdrostat en combinaci\u00f3n con dapagliflozina en participantes con mayor riesgo de desarrollar insuficiencia card\u00edaca.\r\n\r\nCOMPROMISO: 6 screening por mes - 3 rando por mes<br><br><b>BalanceD-HF<\/b><br>\"Estudio de fase III, aleatorizado, doble ciego para evaluar el efecto de balcinrenona\/dapagliflozina, en comparaci\u00f3n con dapagliflozina, sobre el riesgo de episodios de insuficiencia card\u00edaca y muerte cardiovascular en pacientes con insuficiencia card\u00edaca y deterioro de la funci\u00f3n renal (BalanceD-HF)\"<br><br><\/p><\/div><div id=\"mdli15\" class=\"modal pcnt ina15\" style=\"display:none;\"><h2 class=\"fn\">Estudios Finalizados - Cardiometabolico<\/h2><p><b>AZURE-LDL<\/b><br>Un Estudio de Fase III, Aleatorizado, Doble Ciego, Controlado con placebo y de Grupos Paralelos para Evaluar el Efecto de AZD0780 sobre el Colesterol de las Lipoprote\u00ednas de Baja Densidad en pacientes con niveles elevados de colesterol de las lipoprote\u00ednas de baja densidad y Enfermedad Cardiovascular Ateroscler\u00f3tica Cl\u00ednica o en riesgo de padecer un primer Evento de Enfermedad Cardiovascular Ateroscler\u00f3tica.<br><br><b>ACCLAIM-Lp(a) &#8211; J3L-MC-EZEF<\/b><br>Un estudio de Fase 3, randomizado, doble ciego, controlado con placebo para investigar el efecto de Lepodisir\u00e1n en la reducci\u00f3n de eventos adversos cardiovasculares mayores en adultos con lipoprote\u00edna(a) elevada, que presentan enfermedad cardiovascular ateroscler\u00f3tica establecida o corren el riesgo de presentar el primer evento cardiovascular - ACCLAIM-Lp(a)<br><br><b>TRIUMPH<\/b><br>J1I-MC-GZBO\r\n\u201cEstudio en Fase III, aleatorizado, doble ciego, controlado con placebo, basado en eventos para investigar el efecto de la retatrutida sobre la incidencia de los eventos adversos cardiovasculares mayores y el deterioro de la funci\u00f3n renal en participantes con un \u00edndice de masa corporal &gt;=27 kg\/m2 y ateroesclerosis cardiovascular y\/o nefropat\u00eda cr\u00f3nica.\"<br><br><\/p><\/div><\/div><div class=\"item\"><h2>Dermatology<\/h2><a href=\"#mdla16\" rel=\"modal:open\"><button data-id=\"16\" class=\"btn active\">Active Studies<\/button><\/a><a href=\"#mdli16\" rel=\"modal:open\"><button data-id=\"16\" class=\"btn inactive\">Completed Studies<\/button><\/a><div id=\"mdla16\" class=\"modal pcnt act16\" style=\"display:none;\"><h2>Active Studies - Dermatology<\/h2><p><b>INCB 18424-309<\/b><br>Estudio de fase 3, aleatorizado, doble ciego, sobre eficacia y seguridad de la crema de ruxolitinib\r\nen ni\u00f1os (edades &gt;= 6 a\u00f1os a &lt; 12 a\u00f1os) con vit\u00edligo no segmentario.<br><br><\/p><\/div><div id=\"mdli16\" class=\"modal pcnt ina16\" style=\"display:none;\"><h2 class=\"fn\">Completed Studies - Dermatology<\/h2><p><b>INCB 54707-305<\/b><br>Un estudio de fase 3, aleatorizado, doble ciego, controlado con placebo, de eficacia y seguridad de Povorcitiniv en participantes con prurigo nodularis<br><br><b>PSO3001<\/b><br>Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of JNJ-77242113 in the treatment of participants with moderate to severe plaque psoriasis, with randomized withdrawal and retreatment<br><br><b>1368-0098<\/b><br>Randomized, double-blind, placebo-controlled, phase IIb\/phase III study to evaluate the efficacy and safety of spesolimab in patients with moderate to severe hidradenitis suppurativa<br><br><b>INCB 18424-319<\/b><br>Phase III, double-blind, randomized, vehicle-controlled study to evaluate the efficacy and safety of ruxolitinib cream in participants with prurigo nodularis; Topical evaluation of ruxolitinib in nodular prurigo (TRuE-PN1)<br><br><\/p><\/div><\/div><div class=\"item\"><h2>Diabetes<\/h2><a href=\"#mdla17\" rel=\"modal:open\"><button data-id=\"17\" class=\"btn active\">Active Studies<\/button><\/a><a href=\"#mdli17\" rel=\"modal:open\"><button data-id=\"17\" class=\"btn inactive\">Completed Studies<\/button><\/a><div id=\"mdla17\" class=\"modal pcnt act17\" style=\"display:none;\"><h2>Active Studies - Diabetes<\/h2><p><b>EFC18241<\/b><br>Un estudio de fase 3, aleatorizado, doble ciego, de 2 brazos para investigar la eficacia y seguridad de teplizumab en comparaci\u00f3n con placebo en participantes de 1 a 25 a\u00f1os de edad con diagn\u00f3stico reciente de diabetes tipo 1 en etapa 3 (DT1)<br><br><\/p><\/div><div id=\"mdli17\" class=\"modal pcnt ina17\" style=\"display:none;\"><h2 class=\"fn\">Completed Studies - Diabetes<\/h2><p><b>SURPASS-T1D-1<\/b><br>I8F-MC-GPJA: Estudio Fase III, multic\u00e9ntrico, aleatorizado, doble ciego, controlado por placebo, de grupos paralelos para evaluar la eficacia y seguridad de tirzepatida administrado una vez a la semana en comparaci\u00f3n con placebo, en participantes adultos con diabetes tipo 1 y obesidad o sobrepeso (SURPASS-T1D-1).<br><br><b>REIMAGINE 5<\/b><br>NN9388-7741\r\n\u201cEficacia y seguridad de la administraci\u00f3n concomitante de cagrilintida y semaglutida (CagriSema) 1,0 mg\/1,0 mg s.c. una vez a la semana en comparaci\u00f3n con 5 mg s.c. de tirzepatida una vez a la semana en participantes con diabetes tipo 2 controlados inadecuadamente con metformina, inhibidor de SGLT2 o ambos (REIMAGINE 5)\u201d<br><br><b>ACHIEVE-3<\/b><br>J2A-MC-GZGU A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy and Safety of Oral LY3502970 Once Daily Compared to Oral Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin (ACHIEVE-3)<br><br><b>MK 0431-848<\/b><br>MK0431-848\r\n\u201cUn estudio cl\u00ednico de Fase III, multic\u00e9ntrico, randomizado, en doble ciego, controlado con placebo para estudiar la seguridad y eficacia de la adici\u00f3n de Sitagliptina durante el aumento de la dosis de Metformina en comparaci\u00f3n con el aumento de la dosis de Metformina sola en participantes con Diabetes Mellitus Tipo 2\u201d<br><br><b>MK 0431-845<\/b><br>MK0431-845\nPhase III, multicenter, randomized, double-blind, placebo-controlled clinical study to study the efficacy and safety of continued administration of sitagliptin compared to withdrawal of sitagliptin during initiation and titration of insulin glargine (LANTUS\u00ae) in participants with type 2 diabetes mellitus<br><br><b>MK 8835-001<\/b><br>MK 8835-001\n\u201cPhase III, multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of ertugliflozin (MK-8835\/PF-04971729) in subjects with type 2 diabetes mellitus with stage 3 chronic kidney disease, \u201cwhose glycemic control is inadequate with basic antihyperglycemic treatment\u201d<br><br><b>DIA 4003<\/b><br>Protocol 28431754DIA4003\n\u201cRandomized, multicenter, double-blind, parallel, placebo-controlled study of the effects of canagliflozin on renal endpoints in adult subjects with type 2 diabetes mellitus.\u201d<br><br><b>HARMONY<\/b><br>LPG 116174\n\u201cLong-term, randomized, double-blind, placebo-controlled study to determine the effect of albiglutide added to standard blood glucose-lowering therapies on major cardiovascular events in patients with Type 2 diabetes mellitus.\u201d<br><br><b>VERTIS<\/b><br>MK-8835-004-01\/ B1521021\n\u201cRandomized, double-blind, placebo-controlled, parallel-group study to evaluate cardiovascular outcomes after treatment with ertugliflozin (MK-8835\/PF-04971729) in subjects with type 2 diabetes mellitus and established vascular disease,\u201d the cv study \"Vertis.\"<br><br><\/p><\/div><\/div><div class=\"item\"><h2>Endocrinology<\/h2><a href=\"#mdla18\" rel=\"modal:open\"><button data-id=\"18\" class=\"btn active\">Active Studies<\/button><\/a><a href=\"#mdli18\" rel=\"modal:open\"><button data-id=\"18\" class=\"btn inactive\">Completed Studies<\/button><\/a><div id=\"mdla18\" class=\"modal pcnt act18\" style=\"display:none;\"><h2>Estudios Activos - Endocrinolog\u00eda<\/h2><p><b>HICKORY<\/b><br>ALXN1850-HPP-301\r\n\u201cUn estudio de fase 3, aleatorizado, doble ciego, controlado con placebo, multic\u00e9ntrico para evaluar la eficacia y la seguridad de ALXN1850 (Fosfatasa Alcalina Recombinante) administrada por v\u00eda subcut\u00e1nea en participantes adolescentes (de 12 a &lt; 18 a\u00f1os de edad) y adultos con hipofosfatasia que no han sido tratados previamente con Asfotase Alfa\u201d<br><br><b>MULBERRY<\/b><br>ALXN1850-HPP-305\r\n\u201cFase 3, Aleatorizado, Doble Ciego, Controlado con Placebo,\r\nEstudio multic\u00e9ntrico para evaluar la eficacia y la seguridad de ALXN1850 frente a la administraci\u00f3n de placebo Subcut\u00e1neamente en participantes pedi\u00e1tricos sin tratamiento previo (de 2 a &lt; 12 a\u00f1os de edad) con Hipofosfatasia (HPP)\u201d<br><br><b>CHESTNUT<\/b><br>ALXN1850-HPP-303\r\nUn Estudio de Fase 3, Aleatorizado, Abierto, de Grupos Paralelos, con Control Activo y Multic\u00e9ntrico para Evaluar la Seguridad y la Eficacia de ALXN1850 en Comparaci\u00f3n con Asfotasa Alfa Administrada por V\u00eda Subcut\u00e1nea en Participantes Pedi\u00e1tricos (de 2 a &lt; 12 a\u00f1os de edad) con Hipofosfatasia (HPP) Tratados Previamente con Asfotasa Alfa<br><br><\/p><\/div><div id=\"mdli18\" class=\"modal pcnt ina18\" style=\"display:none;\"><h2 class=\"fn\">Estudios Finalizados - Endocrinolog\u00eda<\/h2><p>No hay estudios finalizados en este momento<\/p><\/div><\/div><div class=\"item\"><h2>Gastroenterology<\/h2><a href=\"#mdla19\" rel=\"modal:open\"><button data-id=\"19\" class=\"btn active\">Active Studies<\/button><\/a><a href=\"#mdli19\" rel=\"modal:open\"><button data-id=\"19\" class=\"btn inactive\">Completed Studies<\/button><\/a><div id=\"mdla19\" class=\"modal pcnt act19\" style=\"display:none;\"><h2>Estudios Activos - Gastroenterolog\u00eda<\/h2><p>There are no active studies at this time<\/p><\/div><div id=\"mdli19\" class=\"modal pcnt ina19\" style=\"display:none;\"><h2 class=\"fn\">Completed Studies - Gastroenterology<\/h2><p><b>MK 7240-001<\/b><br>Programa de fase 3, aleatorizado, doble ciego, controlado con placebo para evaluar la eficacia y la seguridad de MK-7240 en participantes con colitis ulcerosa activa de moderada a grave<br><br><b>LIBERTY<\/b><br>\u201cEstudio de fase 2, multic\u00e9ntrico, aleatorizado, doble ciego, controlado con placebo, de grupos paralelos para evaluar la eficacia y seguridad del tratamiento con dupilumab en pacientes con colitis ulcerosa activa de moderada a severa con fenotipo eosinof\u00edlico\u201d<br><br><b>AMG 592 20210210<\/b><br>A Phase 2 Long-Term Extension (LTE) Study to Evaluate the Safety and Efficacy of Efavaleukin Alfa in Subjects With Moderately to Severely Active Ulcerative Colitis<br><br><b>DUET-UC<\/b><br>Estudio de fase 2b aleatorizado, doble ciego, con control activo, de grupos paralelos y multic\u00e9ntrico para evaluar la eficacia y la seguridad de la terapia combinada de inducci\u00f3n y mantenimiento con guselkumab y golimumab en participantes con colitis ulcerosa activa de moderada a grave.<br><br><b>ASTRO<\/b><br>Phase 3, randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the efficacy and safety of subcutaneous induction treatment with Guselkumab in participants with moderately to severely active ulcerative colitis.<br><br><b>CC-93538-EE-02<\/b><br>\u201cEstudio de extensi\u00f3n de fase 3, multic\u00e9ntrico, multinacional, abierto, para evaluar la seguridad a largo plazo de CC-93538 en sujetos adultos y adolescentes con esofagitis eosinif\u00edlica\u201d<br><br><b>AMG592 20170104<\/b><br>A Phase 2, dose-finding, randomized, double-blind, placebo-controlled, multicenter study. To evaluate the safety and efficacy of Efavaleukin alfa in induction therapy in participants with moderately to severely active ulcerative colitis<br><br><b>QUASAR<\/b><br>Ulcerative colitis<br><br><b>RLM-MD-04<\/b><br>RLM-MD-04\n\u201c52-week, randomized, double-blind, placebo-controlled, phase 3 study to evaluate the safety and efficacy of relamorelin in patients with diabetic gastroparesis\u201d<br><br><b>RLM-MD-03<\/b><br>RLM-MD-03\n\u201c46-week, double-blind, placebo-controlled, phase 3 study, with a 6-week randomized drug withdrawal period, to evaluate the safety and efficacy of relamorelin in patients with diabetic gastroparesis\u201d<br><br><\/p><\/div><\/div><div class=\"item\"><h2>Gynecology<\/h2><a href=\"#mdla20\" rel=\"modal:open\"><button data-id=\"20\" class=\"btn active\">Active Studies<\/button><\/a><a href=\"#mdli20\" rel=\"modal:open\"><button data-id=\"20\" class=\"btn inactive\">Completed Studies<\/button><\/a><div id=\"mdla20\" class=\"modal pcnt act20\" style=\"display:none;\"><h2>Active Studies - Gynecology<\/h2><p>There are no active studies at this time<\/p><\/div><div id=\"mdli20\" class=\"modal pcnt ina20\" style=\"display:none;\"><h2 class=\"fn\">Completed Studies - Gynecology<\/h2><p><b>ESTETRA<\/b><br>MIT-Do001-C301: Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Efficacy and Safety of Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort I Study)<br><br><\/p><\/div><\/div><div class=\"item\"><h2>Hepatology<\/h2><a href=\"#mdla21\" rel=\"modal:open\"><button data-id=\"21\" class=\"btn active\">Active Studies<\/button><\/a><a href=\"#mdli21\" rel=\"modal:open\"><button data-id=\"21\" class=\"btn inactive\">Completed Studies<\/button><\/a><div id=\"mdla21\" class=\"modal pcnt act21\" style=\"display:none;\"><h2>Active Studies - Hepatology<\/h2><p>There are no active studies at this time<\/p><\/div><div id=\"mdli21\" class=\"modal pcnt ina21\" style=\"display:none;\"><h2 class=\"fn\">Completed Studies - Hepatology<\/h2><p><b>FORTUNA<\/b><br>Phase IIb\/III, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of cotadutide in participants with non-cirrhotic non-alcoholic steatohepatitis with fibrosis.<br><br><b>K-001-201<\/b><br>\"Estudio de fase 2, multic\u00e9ntrico, controlado con placebo, aleatorizado, doble ciego, de 48 semanas para evaluar la eficacia y seguridad de la terapia combinada de K-877-ER y CSG452 en pacientes con esteatohepatitis no alcoh\u00f3lica no cirr\u00f3tica (NASH) con fibrosis hep\u00e1tica\"<br><br><\/p><\/div><\/div><div class=\"item\"><h2>Infectology<\/h2><a href=\"#mdla22\" rel=\"modal:open\"><button data-id=\"22\" class=\"btn active\">Active Studies<\/button><\/a><a href=\"#mdli22\" rel=\"modal:open\"><button data-id=\"22\" class=\"btn inactive\">Completed Studies<\/button><\/a><div id=\"mdla22\" class=\"modal pcnt act22\" style=\"display:none;\"><h2>Active Studies - Infectology<\/h2><p><b>C5091017<\/b><br>Protocolo C5091017: \r\nUN ESTUDIO INTERVENCIONAL DE EFICACIA Y SEGURIDAD, FASE 3, DOBLE CIEGO, 2 BRAZO PARA INVESTIGAR IBUZATRELVIR ADMINISTRADO POR V\u00cdA ORAL COMPARADO CON PLACEBO EN NO PARTICIPANTES ADULTOS Y ADOLESCENTES SINTOM\u00c1TICOS HOSPITALIZADOS CON COVID-19 OMS TIENEN UN ALTO RIESGO DE PROGRESAR A UNA ENFERMEDAD GRAVE<br><br><\/p><\/div><div id=\"mdli22\" class=\"modal pcnt ina22\" style=\"display:none;\"><h2 class=\"fn\">Completed Studies - Infectology<\/h2><p><b>OTAC INSIGHT 012<\/b><br>INSIGHT 012\r\n\"Ensayo internacional multic\u00e9ntrico, aleatorizado, doble ciego y controlado con placebo sobre la seguridad y la eficacia de la inmunoglobulina hiperinmune intravenosa anti coronavirus para el tratamiento de pacientes adultos ambulatorios en estadios tempranos de la COVID-19\"<br><br><b>RECLAIM<\/b><br>\u201cUn estudio multic\u00e9ntrico, aleatorizado, doble ciego de Fase 3 para evaluar la seguridad y eficacia de contezolida acefosamil y contezolida en comparaci\u00f3n con linezolida administrado por v\u00eda intravenosa y oral a adultos con infecciones moderadas o severas del pie diab\u00e9tico\u201d<br><br><b>VOLITION<\/b><br>A study to evaluate the efficacy, safety, participant choice, and preference of a once-daily oral regimen or a bimonthly long-acting injectable regimen for the treatment of HIV-1 in adults not previously taking antiretroviral therapy.<br><br><b>SUNRISE-3<\/b><br>A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients with COVID-19.<br><br><b>ENANTA<\/b><br>Phase 2b, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of EDP-938 in non-hospitalized adults with acute Respiratory Syncytial Virus infection and at high risk of complications.<br><br><b>SCORPIO-HR<\/b><br>A Phase 3, Multicenter, Randomized, Double-Blind, 24-Week Study of the Clinical and Antiviral Effect of S-217622 Compared to Placebo in Non-Hospitalized Participants With COVID-19<br><br><b>BANNER<\/b><br>Estudio abierto, de fase 2a, multic\u00e9ntrico, aleatorizado, de dos partes, con dise\u00f1o adaptativo, para evaluar el efecto antiviral, la seguridad y la tolerabilidad de GSK3810109A, un anticuerpo monoclonal humano ampliamente neutralizante espec\u00edfico del VIH-1 en adultos infectados por el VIH-1 sin tratamiento previo con antirretrovirales.<br><br><b>TACKLE<\/b><br>\"Estudio fase III, multic\u00e9ntrico, aleatorizado, doble ciego, controlado con placebo, para determinar la seguridad y eficacia de AZD7442 para el tratamiento de COVID-19 en adultos no hospitalizados\"<br><br><\/p><\/div><\/div><div class=\"item\"><h2>Lipids<\/h2><a href=\"#mdla23\" rel=\"modal:open\"><button data-id=\"23\" class=\"btn active\">Active Studies<\/button><\/a><a href=\"#mdli23\" rel=\"modal:open\"><button data-id=\"23\" class=\"btn inactive\">Completed Studies<\/button><\/a><div id=\"mdla23\" class=\"modal pcnt act23\" style=\"display:none;\"><h2>Active Studies - Lipids<\/h2><p>There are no active studies at this time<\/p><\/div><div id=\"mdli23\" class=\"modal pcnt ina23\" style=\"display:none;\"><h2 class=\"fn\">Completed Studies - Lipids<\/h2><p><b>PROMINENT<\/b><br>\u201cPROMINENT Pemafibrate to reduce cardiovascular outcomes by reducing triglycerides in patients with diabetes\u201d<br><br><\/p><\/div><\/div><div class=\"item\"><h2>Nephrology<\/h2><a href=\"#mdla24\" rel=\"modal:open\"><button data-id=\"24\" class=\"btn active\">Active Studies<\/button><\/a><a href=\"#mdli24\" rel=\"modal:open\"><button data-id=\"24\" class=\"btn inactive\">Completed Studies<\/button><\/a><div id=\"mdla24\" class=\"modal pcnt act24\" style=\"display:none;\"><h2>Active Studies - Nephrology<\/h2><p><b>Baxduo PACIFIC<\/b><br>Estudio fase III, aleatorizado, doble ciego, controlado con placebo y dirigido por eventos para evaluar la eficacia, seguridad y tolerabilidad de Baxdrostat en combinaci\u00f3n con dapagliflozina en comparaci\u00f3n con dapagliflozina sola en resultados renales y mortalidad cardiovascular en participantes con enfermedad renal cr\u00f3nica y presi\u00f3n Arterial elevada<br><br><b>POSIBIL_ESKD<\/b><br>Un estudio de fase 2b\/3, multic\u00e9ntrico, aleatorizado, doble ciego, controlado con placebo, combinado de determinaci\u00f3n de dosis y resultados cardiovasculares para investigar la eficacia y seguridad de CSL300 (clazakizumab) en sujetos con insuficiencia renal en fase terminal sometidos a di\u00e1lisis<br><br><\/p><\/div><div id=\"mdli24\" class=\"modal pcnt ina24\" style=\"display:none;\"><h2 class=\"fn\">Completed Studies - Nephrology<\/h2><p><b>BAXDUO Arctic<\/b><br>D6972C00003\r\n\"Un estudio de fase III, aleatorizado, doble ciego y controlado de forma activa para evaluar la eficacia, seguridad y tolerabilidad de baxdrostat en combinaci\u00f3n con dapagliflozina en comparaci\u00f3n con dapagliflozina sola sobre la progresi\u00f3n de la enfermedad renal cr\u00f3nica (ERC) en participantes con ERC y presi\u00f3n arterial alta\"<br><br><b>NN9388-7700<\/b><br>Eficacia y seguridad de cagrilintida s.c. coadministrada. 2,4 mg en combinaci\u00f3n con semaglutida s.c. 2,4 mg (CagriSema s.c. 2,4 mg\/2,4 mg) una vez a la semana en comparaci\u00f3n con semaglutida, cagrilinitida y placebo en personas con enfermedad renal cr\u00f3nica y diabetes tipo 2<br><br><b>TRANSCEND-T2D-3<\/b><br>\u201cEstudio en Fase III, aleatorizado, multic\u00e9ntrico y doble ciego para investigar la eficacia y seguridad de retatrutida administrada una vez a la semana en comparaci\u00f3n con placebo en participantes adultos con diabetes tipo 2, insuficiencia renal moderada o grave con control gluc\u00e9mico inadecuado en la insulina basal con o sin metformina y\/o inhibidor de SGLT2 (TRANSCEND-T2D-3).\u201d<br><br><b>ZENITH<\/b><br>Phase III, Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy, Safety and Tolerability of Zibotentan\/Dapagliflozin Compared to Dapagliflozin Alone in Participants with Chronic Kidney Disease and High Proteinuria<br><br><b>ZENITH HP \/D4325C00007<\/b><br>Study for the Identification and Characterization of Patients with Chronic Kidney Disease and Proteinuria.<br><br><b>BGB-3111-309<\/b><br>BGB-3111-309: un estudio de fase 3, multic\u00e9ntrico, aleatorizado, con control activo y abierto para Evaluar la eficacia y seguridad de zanubrutinib en pacientes con membrana primaria Nefropat\u00eda. Protocolo de estudio, Versi\u00f3n de enero de 2022.<br><br><b>STABILIZE<\/b><br>To evaluate the effect of sodium zirconium cyclosilicate on the progression of chronic kidney disease (CKD) in participants with CKD and hyperkalemia or at risk of hyperkalemia (STABILIZE-CKD)<br><br><b>BI 1378-0005<\/b><br>Randomized, double-blind, placebo-controlled, twelve parallel group study to investigate the efficacy and safety of multiple doses of oral BI 690517 over 14 weeks, alone and in combination with empagliflozin, in patients with diabetes and non-diabetic chronic kidney disease\n6 + 5<br><br><\/p><\/div><\/div><div class=\"item\"><h2>Pulmonology<\/h2><a href=\"#mdla25\" rel=\"modal:open\"><button data-id=\"25\" class=\"btn active\">Active Studies<\/button><\/a><a href=\"#mdli25\" rel=\"modal:open\"><button data-id=\"25\" class=\"btn inactive\">Completed Studies<\/button><\/a><div id=\"mdla25\" class=\"modal pcnt act25\" style=\"display:none;\"><h2>Active Studies - Pulmonology<\/h2><p><b>CBP-201-207<\/b><br>Enfermedad Pulmonar Obstructiva Cr\u00f3nica (EPOC)\/CBP-201-207\r\nEnsayo de fase 2, multic\u00e9ntrico, aleatorizado, doble ciego, de grupos paralelos y controlado con placebo para evaluar la eficacia y seguridad de rademikibart como tratamiento complementario para una exacerbaci\u00f3n aguda en participantes con enfermedad pulmonar obstructiva cr\u00f3nica e inflamaci\u00f3n tipo 2.<br><br><b>ARIA &#8211; GSK 206867<\/b><br>Estudio de fase 3, de 24 semanas, aleatorizado, doble ciego, de grupos paralelos, de modelo din\u00e1mico bayesiano, para comparar la eficacia, seguridad, tolerabilidad y farmacocin\u00e9tica del FF\/UMEC\/VI con la del FF\/VI en participantes de 12 a 17 a\u00f1os con asma inadecuadamente controlada que reciben terapia de mantenimiento estable con CI\/LABA.<br><br><b>DOMINICA<\/b><br>Estudio de fase 3 de eficacia y seguridad de benralizumab en pacientes pedi\u00e1tricos con asma eosinof\u00edlica grave, tiempo hasta la primera exacerbaci\u00f3n del asma, multic\u00e9ntrico, aleatorizado, doble ciego, de grupos paralelos, controlado con placebo<br><br><\/p><\/div><div id=\"mdli25\" class=\"modal pcnt ina25\" style=\"display:none;\"><h2 class=\"fn\">Completed Studies - Pulmonology<\/h2><p><b>PULSEAIR<\/b><br>Ensayo de eficacia y seguridad de 4 semanas, doble ciego, controlado con placebo y de grupos paralelos de una combinaci\u00f3n de propionato de fluticasona\/sulfato de albuterol en comparaci\u00f3n con propionato de fluticasona, sulfato de albuterol o placebo administrados mediante inhalador de polvo seco multidosis en participantes de 12 a\u00f1os o m\u00e1s con asma.<br><br><b>EXHALE 3<\/b><br>Estudio aleatorizado, doble ciego, controlado con placebo y de grupos paralelos para evaluar la eficacia, seguridad y tolerabilidad del dexpramipexol administrado por v\u00eda oral durante 52 semanas en participantes con asma eosinof\u00edlica grave (EXHALE-3)<br><br><b>FLASH<\/b><br>T\u00edtulo: Estudio de fase 2a, aleatorizado, doble ciego, controlado con placebo para evaluar la eficacia y la seguridad de Atuliflapon administrado por v\u00eda oral una vez al d\u00eda durante doce semanas en adultos con asma no controlada de moderada a grave.<br><br><b>EXHALE 2 ARETEIA<\/b><br>AR-DEX-22-01\r\nUn estudio aleatorizado, doble ciego, controlado con placebo y de grupos paralelos para evaluar la eficacia, seguridad y tolerabilidad del dexpramipexol administrado por v\u00eda oral durante 52 semanas en participantes con asma eosinof\u00edlica grave (EXHALE-2)<br><br><b>GB43374 OLE &#8211; ALNASA<\/b><br>Phase III multicenter open-label extension (OLE) study to evaluate the long-term safety and efficacy of astegolimab in combination with standard of care (SOC),<br><br><b>FLAIR<\/b><br>FpA-AS-30094\r\n\r\n\u201cEstudio aleatorizado, doble ciego, multic\u00e9ntrico, con control activo y con grupos paralelos para evaluar la eficacia y seguridad de la combinaci\u00f3n en dosis fijas de propionato de fluticasona\/sulfato de albuterol para las exacerbaciones graves del asma en pacientes con asma\u201d<br><br><b>TANGO<\/b><br>Un ensayo de 52 semanas, aleatorizado, doble ciego, multic\u00e9ntrico, de grupos paralelos de 2 brazos que eval\u00faa la eficacia y seguridad del inhalador de polvo seco (DPI) CHF6001 (dosis diaria total 3200 ug) como complemento al corticosteroide inhalado de dosis media o alta de mantenimiento en combinaci\u00f3n con agonistas \u00df2 de acci\u00f3n prolongada en sujetos con asma no controlada<br><br><\/p><\/div><\/div><div class=\"item\"><h2>Oncology<\/h2><a href=\"#mdla26\" rel=\"modal:open\"><button data-id=\"26\" class=\"btn active\">Active Studies<\/button><\/a><a href=\"#mdli26\" rel=\"modal:open\"><button data-id=\"26\" class=\"btn inactive\">Completed Studies<\/button><\/a><div id=\"mdla26\" class=\"modal pcnt act26\" style=\"display:none;\"><h2>Active Studies - Oncology<\/h2><p><b>DESTINY-Endometrial02 (DE-02)<\/b><br>T\u00edtulo completo del protocolo: Ensayo de fase 3, multic\u00e9ntrico, aleatorizado y abierto de trastuzumab deruxtecan frente al tratamiento est\u00e1ndar (carboplatino en combinaci\u00f3n con paclitaxel) como tratamiento adyuvante del c\u00e1ncer de endometrio con expresi\u00f3n de HER2 (IHC 3+\/IHC2+).<br><br><b>DESTINY<\/b><br>DS8201-724, Ensayo multic\u00e9ntrico, aleatorizado, abierto, de fase 3 de trastuzumab deruxtecan (Enhertu\u00ae) m\u00e1s quimioterapia m\u00e1s o menos pembrolizumab frente a quimioterapia m\u00e1s trastuzumab m\u00e1s o menos pembrolizumab como tratamiento de primera l\u00ednea en participantes con c\u00e1ncer g\u00e1strico o de la uni\u00f3n gastroesof\u00e1gica (UEG) HER2-positivo, localmente avanzado o metast\u00e1sico irresecable (DESTINY-Gastric05)<br><br><b>DS7300-203<\/b><br>DS7300-203: Un estudio abierto de fase 2 pantumoral para evaluar la eficacia y seguridad de Ifinatamab Deruxtecan (I-DXD) en sujetos con tumores s\u00f3lidos recurrentes o metast\u00e1sicos.<br><br><b>BNT323-01<\/b><br>Ensayo abierto de quimioterapia con agente \u00fanico versus quimioterapia elegida por el investigador en pacientes previamente tratadas con c\u00e1ncer de endometrio recurrente o metast\u00e1sico que expresa HER2\r\n\r\nEl compromiso final fueron 3 pacientes screening y 2 pacientes Rando<br><br><\/p><\/div><div id=\"mdli26\" class=\"modal pcnt ina26\" style=\"display:none;\"><h2 class=\"fn\">Completed Studies - Oncology<\/h2><p><b>DYNASTY-Breast02<\/b><br>Estudio de fase 3, aleatorizado, multic\u00e9ntrico y abierto para evaluar DB-1303 en comparaci\u00f3n con la quimioterapia elegida por el investigador en pacientes con c\u00e1ncer de mama metast\u00e1sico con baja expresi\u00f3n del receptor 2 del factor de crecimiento epid\u00e9rmico humano (HER2) y con sobreexpresi\u00f3n del receptor hormonal (HR+) cuya enfermedad ha progresado con el tratamiento endocrino (TE) (DYNASTY-Breast02)<br><br><b>OPERA-01<\/b><br>OP-1250-301\r\n\u201cEstudio de fase 3, aleatorizado, de etiqueta abierta, de monoterapia con OP-1250 frente al est\u00e1ndar de atenci\u00f3n para el tratamiento del c\u00e1ncer de mama ER+, HER2- avanzado o metast\u00e1sico despu\u00e9s de la terapia endocrina y con inhibidores CDK4\/6 (OPERA-01).\u201d<br><br><b>ZINNIA<\/b><br>20210031\r\n\u201cUn estudio doble ciego, aleatorizado para evaluar la eficacia, la seguridad y la inmunogenia de ABP 206 en comparaci\u00f3n con OPDIVO\u00ae (Nivolumab) en sujetos con melanoma irresecable o metast\u00e1sico sin exposici\u00f3n previa al tratamiento\u201d<br><br><b>VERBENA<\/b><br>A randomized, double-blind study to compare the pharmacokinetics, between ABP 206 and Nivolumab (Opdivo\u00ae) in subjects with stage III or IV melanoma resected in the adjuvant setting.<br><br><b>TROPION 02<\/b><br>Phase 3, Open-Label, Randomized Study of Datopotamab Deruxtecan (Dato-DXd) Versus Investigator's Choice of Chemotherapy in Patients With First-Line Inoperable or Metastatic Locally Recurrent Triple-Negative Breast Cancer Who Are Not Candidates for Inhibitor Therapy PD1\/PD-L1 (TROPION Mama02)<br><br><b>lidERA\/TRIO045<\/b><br>Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared to Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)<br><br><\/p><\/div><\/div><div class=\"item\"><h2>Osteoporosis<\/h2><a href=\"#mdla27\" rel=\"modal:open\"><button data-id=\"27\" class=\"btn active\">Active Studies<\/button><\/a><a href=\"#mdli27\" rel=\"modal:open\"><button data-id=\"27\" class=\"btn inactive\">Completed Studies<\/button><\/a><div id=\"mdla27\" class=\"modal pcnt act27\" style=\"display:none;\"><h2>Active Studies - Osteoporosis<\/h2><p>There are no active studies at this time<\/p><\/div><div id=\"mdli27\" class=\"modal pcnt ina27\" style=\"display:none;\"><h2 class=\"fn\">Completed Studies - Osteoporosis<\/h2><p><b>ARTEMIS<\/b><br>Estudio de fase 2, aleatorizado, doble ciego, controlado con placebo, de grupos paralelos y de determinaci\u00f3n de dosis para evaluar la seguridad, la tolerabilidad y la eficacia de AGA2118 en mujeres posmenop\u00e1usicas con baja densidad mineral \u00f3sea.<br><br><\/p><\/div><\/div><div class=\"item\"><h2>Pediatr\u00eda<\/h2><a href=\"#mdla28\" rel=\"modal:open\"><button data-id=\"28\" class=\"btn active\">Active Studies<\/button><\/a><a href=\"#mdli28\" rel=\"modal:open\"><button data-id=\"28\" class=\"btn inactive\">Completed Studies<\/button><\/a><div id=\"mdla28\" class=\"modal pcnt act28\" style=\"display:none;\"><h2>Estudios Activos - Pediatr\u00eda<\/h2><p>There are no active studies at this time<\/p><\/div><div id=\"mdli28\" class=\"modal pcnt ina28\" style=\"display:none;\"><h2 class=\"fn\">Estudios Finalizados - Pediatr\u00eda<\/h2><p><b>LIBELULA<\/b><br>Debio 4326 HAB97073\r\n\"Estudio Fase III, multic\u00e9ntrico, abierto, de un solo brazo; sobre eficacia, seguridad y farmacogen\u00e9tica de Debio 4326, una formulaci\u00f3n de liberaci\u00f3n prolongada de 70mg de acetato de triptorelina, en participantes pedi\u00e1tricos que reciben tratamiento liberador de gonadotropina- Terapia de agon\u00eda hormonal para la pubertad precoz central.\"<br><br><\/p><\/div><\/div><div class=\"item\"><h2>Rheumatology<\/h2><a href=\"#mdla29\" rel=\"modal:open\"><button data-id=\"29\" class=\"btn active\">Active Studies<\/button><\/a><a href=\"#mdli29\" rel=\"modal:open\"><button data-id=\"29\" class=\"btn inactive\">Completed Studies<\/button><\/a><div id=\"mdla29\" class=\"modal pcnt act29\" style=\"display:none;\"><h2>Active Studies - Rheumatology<\/h2><p><b>WA45846<\/b><br>ESTUDIO DE FASE II, MULTIC\u00c9NTRICO, DOBLE CIEGO, CONTROLADO CON PLACEBO PARA EVALUAR LA EFICACIA Y SEGURIDAD DE RO7790121 EN PACIENTES CON ARTRITIS REUMATOIDE DE MODERADA A GRAVE QUE PRESENTAN UNA RESPUESTA INADECUADA O INTOLERANCIA A LOS INHIBIDORES DE TNF Y\/O JAK<br><br><b>BE-EARLY<\/b><br>219240\r\n\u201cEstudio de fase 4, multic\u00e9ntrico, prospectivo y abierto en el que se describe la eficacia y la seguridad del belimumab administrado por v\u00eda subcut\u00e1nea en participantes adultos con lupus eritematoso sist\u00e9mico en fase inicial\u201d<br><br><b>EMERALD<\/b><br>\"Un estudio de extensi\u00f3n a largo plazo, multic\u00e9ntrico, aleatorizado, a ciegas, de fase 3 para evaluar la Seguridad y eficacia de BIIB059 en participantes adultos con lupus eritematoso sist\u00e9mico (LES) activo\"<br><br><\/p><\/div><div id=\"mdli29\" class=\"modal pcnt ina29\" style=\"display:none;\"><h2 class=\"fn\">Completed Studies - Rheumatology<\/h2><p><b>ARGX-113-2306<\/b><br>Ensayo cl\u00ednico de fase 3, multic\u00e9ntrico, aleatorizado, doble ciego, controlado con placebo, con una extensi\u00f3n abierta para evaluar la eficacia, seguridad y tolerabilidad de Efgartigimod PH20 administrado por v\u00eda subcut\u00e1nea mediante jeringa precargada en pacientes adultos con enfermedad de Sj\u00f6gren primaria (ARGX-113-2306)<br><br><b>MK 6194-006<\/b><br>\"Estudio de fase 2, multic\u00e9ntrico, aleatorizado, doble ciego, controlado con placebo para evaluar la eficacia y seguridad de MK-6194 en participantes adultos con lupus eritematoso sist\u00e9mico.\"<br><br><b>APATURA<\/b><br>DRI17821\r\nUn estudio de fase 2, aleatorizado, doble ciego, controlado con placebo, de rango de dosis, eficacia y seguridad de SAR441566 m\u00e1s metotrexato en adultos con artritis reumatoide de moderada a grave.<br><br><b>JASMINE 80202135SLE2001<\/b><br>Phase 2, multicenter, randomized, double-blind, placebo-controlled study of nipocalimab in subjects with active systemic lupus erythematosus (SLE).<br><br><b>VITALISSCE<\/b><br>\u201dEstudio de Fase II, aleatorizado, controlado con placebo, doble ciego, de grupos paralelos, para evaluar la eficacia y la seguridad de, al menos, 48 semanas de tratamiento con BI 685509 oral en adultos con esclerosis sist\u00e9mica progresiva\u201d<br><br><b>MARS-17<\/b><br>Estudio de fase 2, multic\u00e9ntrico, aleatorizado, doble ciego, controlado con placebo, de b\u00fasqueda de dosis (MARS-17) de GSK3858279 en participantes adultos con dolor moderado a severo ocasionado por artrosis de rodilla.<br><br><b>WILLOW LTE  MS200569_0048<\/b><br>Un estudio de fase II, doble ciego, de dosis variable, paralelo y de extensi\u00f3n a largo plazo para evaluar la seguridad y la eficacia de Enpatoran en participantes con lupus eritematoso cut\u00e1neo subagudo, lupus eritematoso discoide y\/o lupus eritematoso sist\u00e9mico que han completado el tratamiento del estudio WILLOW (MS200569_0003)<br><br><\/p><\/div><\/div><\/div><\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"e-n-accordion-item-7211\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"2\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"e-n-accordion-item-7211\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> Our Professionals <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-7211\" class=\"elementor-element elementor-element-35fa11e e-con-full e-flex e-con e-child\" data-id=\"35fa11e\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-201a506 elementor-widget elementor-widget-template\" data-id=\"201a506\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"template.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-template\">\n\t\t\t\t\t<div data-elementor-type=\"page\" data-elementor-id=\"1976\" class=\"elementor elementor-1976\" data-elementor-post-type=\"elementor_library\">\n\t\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-7211\" class=\"elementor-element elementor-element-5e8fe56 e-flex e-con-boxed e-con e-parent\" data-id=\"5e8fe56\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-23917f8 elementor-widget elementor-widget-shortcode\" data-id=\"23917f8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"shortcode.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-shortcode\"><div class=\"profesionales-wrapper\"><h2 class=\"sector-parent\">Authorities<\/h2><div class=\"sector-children\"><div class=\"sector-column\"><h3 class=\"sector-child\">Managing Director<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Dr. Alvarisqueta, Andr\u00e9s Francisco\u200b<\/h3><div class=\"email\"><a href=\"mailto:andres.alvarisqueta@cimmdp.com\">andres.alvarisqueta@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><div class=\"sector-column\"><h3 class=\"sector-child\">Medical director<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Dr. Pereyra, Alejandro Julio\u200b<\/h3><div class=\"email\"><a href=\"mailto:alejandro.pereyra@cimmdp.com\">alejandro.pereyra@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><div class=\"sector-column\"><h3 class=\"sector-child\">Director Asociado<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Dr. Massari, Fabio<\/h3><div class=\"email\"><a href=\"mailto:fabio.massari@cimmdp.com\">fabio.massari@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><\/div><h2 class=\"sector-parent\">Doctors<\/h2><div class=\"sector-children\"><div class=\"sector-column\"><h3 class=\"sector-child\">Internal Medicine and diabetes<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Dr. Alvarisqueta, Andr\u00e9s Francisco\u200b<\/h3><div class=\"email\"><a href=\"mailto:andres.alvarisqueta@cimmdp.com\">andres.alvarisqueta@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Dr. Pereyra, Alejandro Julio\u200b<\/h3><div class=\"email\"><a href=\"mailto:alejandro.pereyra@cimmdp.com\">alejandro.pereyra@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Dr. Hern\u00e1ndez Gauna, Adri\u00e1n\u200b<\/h3><div class=\"email\"><a href=\"mailto:adrian.hernandezgauna@cimmdp.com\">adrian.hernandezgauna@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Dra. Reig, Moira Alejandra\u200b<\/h3><div class=\"email\"><a href=\"mailto:moira.reig@cimmdp.com\">moira.reig@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Dra. Flavia Susana Papa<\/h3><div class=\"email\"><a href=\"mailto:flavia.papa@cimmdp.com\">flavia.papa@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Dr. Javier Agustin Remon<\/h3><div class=\"email\"><a href=\"mailto:javier.remon@cimmdp.com\">javier.remon@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Dra. Soler, Mariana<\/h3><div class=\"email\"><a href=\"mailto:mariana.soler@cimmdp.com\">mariana.soler@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Dr. Su\u00e1rez, Walter Gabriel<\/h3><div class=\"email\"><a href=\"mailto:gabriel.suarez@cimmdp.com\">gabriel.suarez@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><div class=\"sector-column\"><h3 class=\"sector-child\">Nutrition<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Melisa Maldonado<\/h3><div class=\"email\"><a href=\"mailto:melisa.maldonado@cimmdp.com\">melisa.maldonado@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><div class=\"sector-column\"><h3 class=\"sector-child\">Ophthalmology<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Dr. Berra, Federico<\/h3><div class=\"email\"><a href=\"mailto:federico.berra@cimmdp.com\">federico.berra@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><div class=\"sector-column\"><h3 class=\"sector-child\">Nephrology<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Dr. Iros, Horacio Jos\u00e9<\/h3><div class=\"email\"><a href=\"mailto:horacio.iros@cimmdp.com\">horacio.iros@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><div class=\"sector-column\"><h3 class=\"sector-child\">Infectology<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Dr. Ferro, Alejandro<\/h3><div class=\"email\"><a href=\"mailto:alejandro.ferro@cimmdp.com\">alejandro.ferro@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Dra. Mariana Hualde<\/h3><div class=\"email\"><a href=\"mailto:mariana.hualde@cimmdp.com\">mariana.hualde@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Dra. Cristina Ines Miglioranza<\/h3><div class=\"email\"><a href=\"mailto:ines.miglioranza@cimmdp.com\">ines.miglioranza@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Dr. Alexis Manzo<\/h3><div class=\"email\"><a href=\"mailto:alexis.manzo@cimmdp.com\">alexis.manzo@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Dr. Jose Iriart<\/h3><div class=\"email\"><a href=\"mailto:jose.iriart@cimmdp.com\">jose.iriart@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><div class=\"sector-column\"><h3 class=\"sector-child\">Dermatology<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Dra. Catuogno, Mar\u00eda Florencia\u200b\u200b<\/h3><div class=\"email\"><a href=\"mailto:florencia.catuogno@cimmdp.com\">florencia.catuogno@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><div class=\"sector-column\"><h3 class=\"sector-child\">Pulmonology<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Manuel Naveyra<\/h3><div class=\"email\"><a href=\"mailto:manuel.naveyra@cimmdp.com\">manuel.naveyra@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Dr. Guillermo Monaldi<\/h3><div class=\"email\"><a href=\"mailto:guillermomonaldi@cimmdp.com\">guillermomonaldi@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Dr. Taborda, Jorge Bernardo<\/h3><div class=\"email\"><a href=\"mailto:jorge.taborda@cimmdp.com\">jorge.taborda@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><div class=\"sector-column\"><h3 class=\"sector-child\">Hematology<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Dr. Ferreras, Roberto<\/h3><div class=\"email\"><a href=\"mailto:roberto.ferreras@cimmdp.com\">roberto.ferreras@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Dra. Pisani, Alejandra<\/h3><div class=\"email\"><a href=\"mailto:alejandra.pisani@cimmdp.com\">alejandra.pisani@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><div class=\"sector-column\"><h3 class=\"sector-child\">Rheumatology<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Dra. Iturralde Carolina<\/h3><div class=\"email\"><a href=\"mailto:carolina.iturralde@cimmdp.com\">carolina.iturralde@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><div class=\"sector-column\"><h3 class=\"sector-child\">Gastroenterology<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Dra. Mor\u00e1n, Gabriela Loreta<\/h3><div class=\"email\"><a href=\"mailto:gabriela.moran@cimmdp.com\">gabriela.moran@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><div class=\"sector-column\"><h3 class=\"sector-child\">Oncology<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Dr. Alvarez Juan Pablo \u200b<\/h3><div class=\"email\"><a href=\"mailto:juanpablo.alvarez@cimmdp.com\">juanpablo.alvarez@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Dr. Descalzo, Jos\u00e9 Mar\u00eda \u200b<\/h3><div class=\"email\"><a href=\"mailto:josemaria.descalzo@cimmdp.com\">josemaria.descalzo@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Dr. Arturo Barbero \u200b<\/h3><div class=\"email\"><a href=\"mailto:arturo.barbero@cimmdp.com\">arturo.barbero@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><div class=\"sector-column\"><h3 class=\"sector-child\">Endocrinology<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Dra. Colantonio, Mariela<\/h3><div class=\"email\"><a href=\"mailto:mariela.colantonio@cimmdp.com\">mariela.colantonio@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><div class=\"sector-column\"><h3 class=\"sector-child\">Vaccines and Pediatrics<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Dr. Perino, Juan<\/h3><div class=\"email\"><a href=\"mailto:juan.perino@cimmdp.com\">juan.perino@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><\/div><h2 class=\"sector-parent\">Study Coordinators<\/h2><div class=\"sector-children\"><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Alcazar, Ruth<\/h3><div class=\"email\"><a href=\"mailto:ruth.alcazar@cimmdp.com\">ruth.alcazar@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Blanco, Ana<\/h3><div class=\"email\"><a href=\"mailto:ana.blanco@cimmdp.com\">ana.blanco@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>De Gennaro, Jessica<\/h3><div class=\"email\"><a href=\"mailto:jessica.degennaro@cimmdp.com\">jessica.degennaro@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>De Gennaro, Natalia Laura<\/h3><div class=\"email\"><a href=\"mailto:natalia.degennaro@cimmdp.com\">natalia.degennaro@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Del Castello, Fiorella<\/h3><div class=\"email\"><a href=\"mailto:fiorella.delcastello@cimmdp.com\">fiorella.delcastello@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Figueroa, Germana Mar\u00eda\u200b<\/h3><div class=\"email\"><a href=\"mailto:germana.figueroa@cimmdp.com\">germana.figueroa@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Fontan, Sofia<\/h3><div class=\"email\"><a href=\"mailto:sofia.fontan@cimmdp.com\">sofia.fontan@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Ginel, Malena<\/h3><div class=\"email\"><a href=\"mailto:malena.ginel@cimmdp.com\">malena.ginel@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Ojeda, Milagros<\/h3><div class=\"email\"><a href=\"mailto:milagro.ojeda@cimmdp.com\">milagro.ojeda@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>P\u00e9rez, Eliana Sof\u00eda\u200b<\/h3><div class=\"email\"><a href=\"mailto:eliana.perez@cimmdp.com\">eliana.perez@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Regidor, Victoria<\/h3><div class=\"email\"><a href=\"mailto:victoria.regidor@cimmdp.com\">victoria.regidor@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Riveros, Carolina<\/h3><div class=\"email\"><a href=\"mailto:carolina.riveros@cimmdp.com\">carolina.riveros@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><h2 class=\"sector-parent\">Nursing<\/h2><div class=\"sector-children\"><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Leiva, Carolina<\/h3><div class=\"email\"><a href=\"mailto:carolina.leiva@cimmdp.com\">carolina.leiva@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><h2 class=\"sector-parent\">Espirometr\u00eda<\/h2><div class=\"sector-children\"><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Lucas Modarelli<\/h3><div class=\"email\"><a href=\"mailto:lucas.modarelli@cimmdp.com\">lucas.modarelli@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Andrea Taborda<\/h3><div class=\"email\"><a href=\"mailto:andrea.taborda@cimmdp.com\">andrea.taborda@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><h2 class=\"sector-parent\">Laboratory<\/h2><div class=\"sector-children\"><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Godoy, Eugenia<\/h3><div class=\"email\"><a href=\"mailto:eugenia.godoy@cimmdp.com\">eugenia.godoy@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Hernandez, Anabela<\/h3><div class=\"email\"><a href=\"mailto:anabela.hernandez@cimmdp.com\">anabela.hernandez@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Sosa, \u00c9rica Gisela<\/h3><div class=\"email\"><a href=\"mailto:erica.sosa@cimmdp.com\">erica.sosa@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><h2 class=\"sector-parent\">Biochemistry<\/h2><div class=\"sector-children\"><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Figueroa, Germana Mar\u00eda\u200b<\/h3><div class=\"email\"><a href=\"mailto:germana.figueroa@cimmdp.com\">germana.figueroa@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Regidor, Victoria<\/h3><div class=\"email\"><a href=\"mailto:victoria.regidor@cimmdp.com\">victoria.regidor@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><h2 class=\"sector-parent\">Regulatory - Start Up<\/h2><div class=\"sector-children\"><div class=\"sector-column\"><h3 class=\"sector-child\">Regulatory Area Assistant<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Pablo Tortone<\/h3><div class=\"email\"><a href=\"mailto:pablo.tortone@cimmdp.com\">pablo.tortone@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><\/div><h2 class=\"sector-parent\">Recruitment<\/h2><div class=\"sector-children\"><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Avella, Gian Marco Claudio<\/h3><div class=\"email\"><a href=\"mailto:relacionesprofesionales@cimmdp.com\">relacionesprofesionales@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Montarce, Florencia<\/h3><div class=\"email\"><a href=\"mailto:florencia.montarce@cimmdp.com\">florencia.montarce@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><h2 class=\"sector-parent\">Executive Area<\/h2><div class=\"sector-children\"><div class=\"sector-column\"><h3 class=\"sector-child\">Operational Manager<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Arbaizagoitia, Gustavo\u200b<\/h3><div class=\"email\"><a href=\"mailto:gustavo.arbaizagoitia@cimmdp.com\">gustavo.arbaizagoitia@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><div class=\"sector-column\"><h3 class=\"sector-child\">Administrative manager<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Fortuny, Rodrigo\u200b<\/h3><div class=\"email\"><a href=\"mailto:rodrigo.fortuny@cimmdp.com\">rodrigo.fortuny@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><div class=\"sector-column\"><h3 class=\"sector-child\">Administrative assistant<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Scenna, Andres\u200b<\/h3><div class=\"email\"><a href=\"mailto:andres.scenna@cimmdp.com\">andres.scenna@cimmdp.com<\/a><\/div><\/li><li class=\"profesional-item\"><h3>Fortuny, Nicolas<\/h3><div class=\"email\"><a href=\"mailto:nicolas.fortuny@cimmdp.com\">nicolas.fortuny@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><div class=\"sector-column\"><h3 class=\"sector-child\">Human Resources Manager<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Mikucki, Julieta<\/h3><div class=\"email\"><a href=\"mailto:recursoshumanos@cimmdp.com\">recursoshumanos@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><div class=\"sector-column\"><h3 class=\"sector-child\">Asistente de Direcci\u00f3n<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Carucci, Paula<\/h3><div class=\"email\"><a href=\"mailto:paula.carucci@cimmdp.com\">paula.carucci@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><div class=\"sector-column\"><h3 class=\"sector-child\">Communication Coordinator<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Antezana de la Rivera, Luciana<\/h3><div class=\"email\"><a href=\"mailto:luciana.antezana@cimmdp.com\">luciana.antezana@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><div class=\"sector-column\"><h3 class=\"sector-child\">IT<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Simkin, Sebasti\u00e1n\u200b<\/h3><div class=\"email\"><a href=\"mailto:sebastian.simkin@cimmdp.com\">sebastian.simkin@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><div class=\"sector-column\"><h3 class=\"sector-child\">Secretariat<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Iparraguirre, Alejandra<\/h3><div class=\"email\"><a href=\"mailto:secretaria@cimmdp.com\">secretaria@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><div class=\"sector-column\"><h3 class=\"sector-child\">Secretar\u00eda Laboratorio<\/h3><ul class=\"profesionales-list\"><li class=\"profesional-item\"><h3>Olaechea, Debora<\/h3><div class=\"email\"><a href=\"mailto:debora.olaechea@cimmdp.com\">debora.olaechea@cimmdp.com<\/a><\/div><\/li><\/ul><\/div><\/div><\/div><\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"e-n-accordion-item-7212\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"3\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"e-n-accordion-item-7212\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> Infrastructure <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-7212\" class=\"elementor-element elementor-element-460b6a4 e-flex e-con-boxed e-con e-child\" data-id=\"460b6a4\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-31082eb elementor-widget elementor-widget-template\" data-id=\"31082eb\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"template.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-template\">\n\t\t\t\t\t<div data-elementor-type=\"section\" data-elementor-id=\"1969\" class=\"elementor elementor-1969\" data-elementor-post-type=\"elementor_library\">\n\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-7212\" class=\"elementor-element elementor-element-aef7a82 e-flex e-con-boxed e-con e-child\" data-id=\"aef7a82\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-7212\" class=\"elementor-element elementor-element-9bad283 e-con-full e-flex e-con e-child\" data-id=\"9bad283\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-9a046b5 elementor-widget elementor-widget-heading\" data-id=\"9a046b5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Facilities<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-14fd9a2 elementor-icon-list--layout-traditional elementor-list-item-link-full_width elementor-widget elementor-widget-icon-list\" data-id=\"14fd9a2\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon-list.default\">\n\t\t\t\t\t\t\t<ul class=\"elementor-icon-list-items\">\n\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">450 square meters<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">10 Offices<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Box for sample extraction<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Box for ECG performance<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Wardrobe for patients<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Pharmacy with security code, alarm and cold chain <\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Calibrated thermometers<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Lockable storage location for files and medical records<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Storage space with security code for returned medication.<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Monitoring room<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Breakfast area for patients<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Protected cardio space<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-7212\" class=\"elementor-element elementor-element-adaf2e4 e-con-full e-flex e-con e-child\" data-id=\"adaf2e4\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1547b75 elementor-widget elementor-widget-heading\" data-id=\"1547b75\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Technology<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-729cef9 elementor-icon-list--layout-traditional elementor-list-item-link-full_width elementor-widget elementor-widget-icon-list\" data-id=\"729cef9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon-list.default\">\n\t\t\t\t\t\t\t<ul class=\"elementor-icon-list-items\">\n\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Fully computerized center<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Protected digital information<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">24 hour fax with direct line<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Printer with scanner on each floor<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Generator set to ensure cold chain in pharmacy<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Wifi<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">24 hour monitoring<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-7212\" class=\"elementor-element elementor-element-1cc28cf e-con-full e-flex e-con e-child\" data-id=\"1cc28cf\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-4421da5 elementor-widget elementor-widget-heading\" data-id=\"4421da5\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Equipment<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-394618c elementor-icon-list--layout-traditional elementor-list-item-link-full_width elementor-widget elementor-widget-icon-list\" data-id=\"394618c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"icon-list.default\">\n\t\t\t\t\t\t\t<ul class=\"elementor-icon-list-items\">\n\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Refrigerators and freezers with calibrated thermometers<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Laminar flow hood Blood pressure monitors<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Roma scales<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">2 Centrifuges<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Incubator<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Electrocardiograph<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Spirometer<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Defibrillator<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t<li class=\"elementor-icon-list-item\">\n\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-icon\">\n\t\t\t\t\t\t\t<svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-check-circle\" viewbox=\"0 0 512 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M504 256c0 136.967-111.033 248-248 248S8 392.967 8 256 119.033 8 256 8s248 111.033 248 248zM227.314 387.314l184-184c6.248-6.248 6.248-16.379 0-22.627l-22.627-22.627c-6.248-6.249-16.379-6.249-22.628 0L216 308.118l-70.059-70.059c-6.248-6.248-16.379-6.248-22.628 0l-22.627 22.627c-6.248 6.248-6.248 16.379 0 22.627l104 104c6.249 6.249 16.379 6.249 22.628.001z\"><\/path><\/svg>\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-icon-list-text\">Cabinet with basket for pathological waste and periodic withdrawals by Environmental Systems<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-7212\" class=\"elementor-element elementor-element-b5bb875 e-flex e-con-boxed e-con e-parent\" data-id=\"b5bb875\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-c9debb8 elementor-widget elementor-widget-gallery\" data-id=\"c9debb8\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;columns&quot;:3,&quot;gap&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:0,&quot;sizes&quot;:[]},&quot;overlay_title&quot;:&quot;caption&quot;,&quot;lazyload&quot;:&quot;yes&quot;,&quot;gallery_layout&quot;:&quot;grid&quot;,&quot;columns_tablet&quot;:2,&quot;columns_mobile&quot;:1,&quot;gap_tablet&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:10,&quot;sizes&quot;:[]},&quot;gap_mobile&quot;:{&quot;unit&quot;:&quot;px&quot;,&quot;size&quot;:10,&quot;sizes&quot;:[]},&quot;link_to&quot;:&quot;file&quot;,&quot;aspect_ratio&quot;:&quot;3:2&quot;,&quot;overlay_background&quot;:&quot;yes&quot;,&quot;content_hover_animation&quot;:&quot;fade-in&quot;}\" data-widget_type=\"gallery.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-gallery__container\">\n\t\t\t\t\t\t\t<a class=\"e-gallery-item elementor-gallery-item elementor-animated-content\" href=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2020\/08\/pic1.jpg\" data-elementor-open-lightbox=\"yes\" data-elementor-lightbox-slideshow=\"c9debb8\" data-elementor-lightbox-title=\"pic1\" data-e-action-hash=\"#elementor-action%3Aaction%3Dlightbox%26settings%3DeyJpZCI6MTQ0LCJ1cmwiOiJodHRwczpcL1wvd3d3LmNpbW1kcC5jb20uYXJcL3dwLWNvbnRlbnRcL3VwbG9hZHNcLzIwMjBcLzA4XC9waWMxLmpwZyIsInNsaWRlc2hvdyI6ImM5ZGViYjgifQ%3D%3D\">\n\t\t\t\t\t<div class=\"e-gallery-image elementor-gallery-item__image\" data-thumbnail=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2020\/08\/pic1.jpg\" data-width=\"643\" data-height=\"425\" aria-label=\"\" role=\"img\" ><\/div>\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-gallery-item__overlay\"><\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-gallery-item__content\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-gallery-item__title\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tAccess to laboratory, dining room and monitoring room\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<a class=\"e-gallery-item elementor-gallery-item elementor-animated-content\" href=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2020\/08\/pic2.jpg\" data-elementor-open-lightbox=\"yes\" data-elementor-lightbox-slideshow=\"c9debb8\" data-elementor-lightbox-title=\"pic2\" data-e-action-hash=\"#elementor-action%3Aaction%3Dlightbox%26settings%3DeyJpZCI6MTQ1LCJ1cmwiOiJodHRwczpcL1wvd3d3LmNpbW1kcC5jb20uYXJcL3dwLWNvbnRlbnRcL3VwbG9hZHNcLzIwMjBcLzA4XC9waWMyLmpwZyIsInNsaWRlc2hvdyI6ImM5ZGViYjgifQ%3D%3D\">\n\t\t\t\t\t<div class=\"e-gallery-image elementor-gallery-item__image\" data-thumbnail=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2020\/08\/pic2.jpg\" data-width=\"643\" data-height=\"425\" aria-label=\"\" role=\"img\" ><\/div>\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-gallery-item__overlay\"><\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-gallery-item__content\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-gallery-item__title\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tMonitoring room\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<a class=\"e-gallery-item elementor-gallery-item elementor-animated-content\" href=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2020\/08\/pic3.jpg\" data-elementor-open-lightbox=\"yes\" data-elementor-lightbox-slideshow=\"c9debb8\" data-elementor-lightbox-title=\"pic3\" data-e-action-hash=\"#elementor-action%3Aaction%3Dlightbox%26settings%3DeyJpZCI6MTQ2LCJ1cmwiOiJodHRwczpcL1wvd3d3LmNpbW1kcC5jb20uYXJcL3dwLWNvbnRlbnRcL3VwbG9hZHNcLzIwMjBcLzA4XC9waWMzLmpwZyIsInNsaWRlc2hvdyI6ImM5ZGViYjgifQ%3D%3D\">\n\t\t\t\t\t<div class=\"e-gallery-image elementor-gallery-item__image\" data-thumbnail=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2020\/08\/pic3.jpg\" data-width=\"643\" data-height=\"425\" aria-label=\"\" role=\"img\" ><\/div>\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-gallery-item__overlay\"><\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-gallery-item__content\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-gallery-item__title\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tLaboratory waiting room\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<a class=\"e-gallery-item elementor-gallery-item elementor-animated-content\" href=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2020\/08\/pic4.jpg\" data-elementor-open-lightbox=\"yes\" data-elementor-lightbox-slideshow=\"c9debb8\" data-elementor-lightbox-title=\"pic4\" data-e-action-hash=\"#elementor-action%3Aaction%3Dlightbox%26settings%3DeyJpZCI6MTQ3LCJ1cmwiOiJodHRwczpcL1wvd3d3LmNpbW1kcC5jb20uYXJcL3dwLWNvbnRlbnRcL3VwbG9hZHNcLzIwMjBcLzA4XC9waWM0LmpwZyIsInNsaWRlc2hvdyI6ImM5ZGViYjgifQ%3D%3D\">\n\t\t\t\t\t<div class=\"e-gallery-image elementor-gallery-item__image\" data-thumbnail=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2020\/08\/pic4.jpg\" data-width=\"643\" data-height=\"425\" aria-label=\"\" role=\"img\" ><\/div>\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-gallery-item__overlay\"><\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-gallery-item__content\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-gallery-item__title\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tECG room \t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<a class=\"e-gallery-item elementor-gallery-item elementor-animated-content\" href=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2020\/08\/pic5.jpg\" data-elementor-open-lightbox=\"yes\" data-elementor-lightbox-slideshow=\"c9debb8\" data-elementor-lightbox-title=\"pic5\" data-e-action-hash=\"#elementor-action%3Aaction%3Dlightbox%26settings%3DeyJpZCI6MTQ4LCJ1cmwiOiJodHRwczpcL1wvd3d3LmNpbW1kcC5jb20uYXJcL3dwLWNvbnRlbnRcL3VwbG9hZHNcLzIwMjBcLzA4XC9waWM1LmpwZyIsInNsaWRlc2hvdyI6ImM5ZGViYjgifQ%3D%3D\">\n\t\t\t\t\t<div class=\"e-gallery-image elementor-gallery-item__image\" data-thumbnail=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2020\/08\/pic5.jpg\" data-width=\"643\" data-height=\"425\" aria-label=\"\" role=\"img\" ><\/div>\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-gallery-item__overlay\"><\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-gallery-item__content\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-gallery-item__title\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t1st floor office\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<a class=\"e-gallery-item elementor-gallery-item elementor-animated-content\" href=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2020\/08\/pic6.jpg\" data-elementor-open-lightbox=\"yes\" data-elementor-lightbox-slideshow=\"c9debb8\" data-elementor-lightbox-title=\"pic6\" data-e-action-hash=\"#elementor-action%3Aaction%3Dlightbox%26settings%3DeyJpZCI6MTQ5LCJ1cmwiOiJodHRwczpcL1wvd3d3LmNpbW1kcC5jb20uYXJcL3dwLWNvbnRlbnRcL3VwbG9hZHNcLzIwMjBcLzA4XC9waWM2LmpwZyIsInNsaWRlc2hvdyI6ImM5ZGViYjgifQ%3D%3D\">\n\t\t\t\t\t<div class=\"e-gallery-image elementor-gallery-item__image\" data-thumbnail=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2020\/08\/pic6.jpg\" data-width=\"643\" data-height=\"425\" aria-label=\"\" role=\"img\" ><\/div>\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-gallery-item__overlay\"><\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-gallery-item__content\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"elementor-gallery-item__title\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tReception and waiting room floor 1\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t\t<details id=\"e-n-accordion-item-7213\" class=\"e-n-accordion-item\" >\n\t\t\t\t<summary class=\"e-n-accordion-item-title\" data-accordion-index=\"4\" tabindex=\"-1\" aria-expanded=\"false\" aria-controls=\"e-n-accordion-item-7213\" >\n\t\t\t\t\t<span class='e-n-accordion-item-title-header'><div class=\"e-n-accordion-item-title-text\"> Our Sponsors <\/div><\/span>\n\t\t\t\t\t\t\t<span class='e-n-accordion-item-title-icon'>\n\t\t\t<span class='e-opened' ><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-minus\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t<span class='e-closed'><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-plus\" viewbox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t<\/span>\n\n\t\t\t\t\t\t<\/summary>\n\t\t\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-7213\" class=\"elementor-element elementor-element-8fe0bb5 e-flex e-con-boxed e-con e-child\" data-id=\"8fe0bb5\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div role=\"region\" aria-labelledby=\"e-n-accordion-item-7213\" class=\"elementor-element elementor-element-d2aa42f e-con-full e-flex e-con e-child\" data-id=\"d2aa42f\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-997dbaf gallery-spacing-custom elementor-widget elementor-widget-image-gallery\" data-id=\"997dbaf\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image-gallery.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-image-gallery\">\n\t\t\t<div id='gallery-1' class='gallery galleryid-2689 gallery-columns-6 gallery-size-medium'><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/abbvie.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/abbvie.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/abbvie-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/akebia.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/akebia.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/akebia-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/allergan.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/allergan.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/allergan-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/alnylam.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/alnylam.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/alnylam-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/amgen.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/amgen.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/amgen-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/angitia.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/angitia.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/angitia-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/apellis.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/apellis.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/apellis-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/areteia.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/areteia.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/areteia-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/argenx.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/argenx.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/argenx-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/astrazeneca.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/astrazeneca.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/astrazeneca-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/aviragen.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/aviragen.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/aviragen-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/bayer.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/bayer.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/bayer-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/biogen.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/biogen.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/biogen-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/biontech.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/biontech.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/biontech-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/biota.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/biota.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/biota-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/boheringer-ingelheim.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/boheringer-ingelheim.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/boheringer-ingelheim-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/bristol-myers-squibb.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/bristol-myers-squibb.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/bristol-myers-squibb-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/chiesi.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/chiesi.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/chiesi-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/connect.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/connect.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/connect-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/csl.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/csl.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/csl-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/daiichi.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/daiichi.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/daiichi-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/debiopharm.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/debiopharm.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/debiopharm-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/dualiity.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/dualiity.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/dualiity-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/esperion.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/esperion.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/esperion-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/generate.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/generate.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/generate-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/genetech.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/genetech.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/genetech-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/gilead.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/gilead.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/gilead-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/gsk.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/gsk.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/gsk-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/incyte.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/incyte.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/incyte-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/janssen.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/janssen.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/janssen-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/kailera.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/kailera.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/kailera-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/kowa.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/kowa.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/kowa-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/lilly.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/lilly.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/lilly-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/mallinckrodt.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/mallinckrodt.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/mallinckrodt-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/merck.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/merck.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/merck-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/msd.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/msd.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/msd-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/novartis.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/novartis.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/novartis-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/novo-nordisk.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/novo-nordisk.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/novo-nordisk-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/olema.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/olema.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/olema-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/pearl.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/pearl.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/pearl-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/pfizer.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/pfizer.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/pfizer-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/regeneron.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/regeneron.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/regeneron-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/roche.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/roche.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/roche-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/r-pharm.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/r-pharm.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/r-pharm-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/sanofi-aventis.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/sanofi-aventis.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/sanofi-aventis-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/takeda.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/takeda.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/takeda-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/teva.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/teva.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/teva-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/upstream.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/upstream.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/upstream-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/vor.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/vor.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/vor-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure>\n\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f36857c elementor-widget__width-inherit elementor-widget elementor-widget-heading\" data-id=\"f36857c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">CRO's<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7610564 gallery-spacing-custom elementor-widget elementor-widget-image-gallery\" data-id=\"7610564\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image-gallery.default\">\n\t\t\t\t\t\t\t<div class=\"elementor-image-gallery\">\n\t\t\t<div id='gallery-2' class='gallery galleryid-2689 gallery-columns-6 gallery-size-medium'><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/activa.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/activa.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/activa-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/cical.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/cical.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/cical-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/covance.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/covance.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/covance-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/ehealthsolutions.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/ehealthsolutions.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/ehealthsolutions-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/icon-1.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/icon-1.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/icon-1-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/iqvia.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/iqvia.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/iqvia-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/parexel.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/parexel.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/parexel-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/ppd.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/ppd.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/ppd-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/pra.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/pra.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/pra-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/propharma.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/propharma.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/propharma-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/resolution.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/resolution.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/resolution-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/syneos.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/syneos.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/syneos-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/tri.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/tri.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/tri-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon landscape'>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"213\" height=\"92\" src=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/woldwide.jpg\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/woldwide.jpg 213w, https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2026\/03\/woldwide-18x8.jpg 18w\" sizes=\"(max-width: 213px) 100vw, 213px\" \/>\n\t\t\t<\/div><\/figure>\n\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/details>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>\u00c1reas terap\u00e9uticas y Protocolos Cardiolog\u00eda Estudios ActivosEstudios Finalizados Estudios Activos &#8211; Cardiolog\u00eda EASi-HF ReducedT\u00edtulo del protocolo: EASi-HF Reduced: ensayo de superioridad de fase III, doble ciego, aleatorizado y de grupos paralelos para evaluar la eficacia y la seguridad del uso combinado de BI 690517 oral y empagliflozina en comparaci\u00f3n con placebo y empagliflozina en participantes [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1998,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-1917","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Patrocinadores - Centro de Investigaciones M\u00e9dicas<\/title>\n<meta name=\"description\" content=\"M\u00e1s de 120 estudios con un estricto seguimiento de las Buenas Pr\u00e1cticas Cl\u00ednicas y un alto grado de profesionalismo.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cimmdp.com.ar\/en\/sponsors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Patrocinadores - Centro de Investigaciones M\u00e9dicas\" \/>\n<meta property=\"og:description\" content=\"M\u00e1s de 120 estudios con un estricto seguimiento de las Buenas Pr\u00e1cticas Cl\u00ednicas y un alto grado de profesionalismo.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cimmdp.com.ar\/en\/sponsors\/\" \/>\n<meta property=\"og:site_name\" content=\"Centro de Investigaciones M\u00e9dicas\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-05T14:26:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2024\/05\/patrocinadores.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"610\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"26 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cimmdp.com.ar\\\/patrocinadores\\\/\",\"url\":\"https:\\\/\\\/www.cimmdp.com.ar\\\/patrocinadores\\\/\",\"name\":\"Patrocinadores - Centro de Investigaciones M\u00e9dicas\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cimmdp.com.ar\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cimmdp.com.ar\\\/patrocinadores\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cimmdp.com.ar\\\/patrocinadores\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cimmdp.com.ar\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/patrocinadores.jpg\",\"datePublished\":\"2024-05-25T21:32:33+00:00\",\"dateModified\":\"2026-06-05T14:26:18+00:00\",\"description\":\"M\u00e1s de 120 estudios con un estricto seguimiento de las Buenas Pr\u00e1cticas Cl\u00ednicas y un alto grado de profesionalismo.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cimmdp.com.ar\\\/patrocinadores\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cimmdp.com.ar\\\/patrocinadores\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cimmdp.com.ar\\\/patrocinadores\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cimmdp.com.ar\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/patrocinadores.jpg\",\"contentUrl\":\"https:\\\/\\\/www.cimmdp.com.ar\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/patrocinadores.jpg\",\"width\":1920,\"height\":610},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cimmdp.com.ar\\\/patrocinadores\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/www.cimmdp.com.ar\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Patrocinadores\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cimmdp.com.ar\\\/#website\",\"url\":\"https:\\\/\\\/www.cimmdp.com.ar\\\/\",\"name\":\"Centro de Investigaciones M\u00e9dicas\",\"description\":\"Equipo m\u00e9dico altamente calificado con una amplia trayectoria en Investigaci\u00f3n Cl\u00ed\u00adnica\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cimmdp.com.ar\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cimmdp.com.ar\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cimmdp.com.ar\\\/#organization\",\"name\":\"Centro de Investigaciones M\u00e9dicas\",\"url\":\"https:\\\/\\\/www.cimmdp.com.ar\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cimmdp.com.ar\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cimmdp.com.ar\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/centro-de-investigaciones-medicas-mdp-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.cimmdp.com.ar\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/centro-de-investigaciones-medicas-mdp-logo.png\",\"width\":235,\"height\":70,\"caption\":\"Centro de Investigaciones M\u00e9dicas\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cimmdp.com.ar\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sponsors - Centro de Investigaciones M\u00e9dicas","description":"More than 120 studies with strict monitoring of Good Clinical Practices and a high degree of professionalism.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cimmdp.com.ar\/en\/sponsors\/","og_locale":"en_US","og_type":"article","og_title":"Patrocinadores - Centro de Investigaciones M\u00e9dicas","og_description":"M\u00e1s de 120 estudios con un estricto seguimiento de las Buenas Pr\u00e1cticas Cl\u00ednicas y un alto grado de profesionalismo.","og_url":"https:\/\/www.cimmdp.com.ar\/en\/sponsors\/","og_site_name":"Centro de Investigaciones M\u00e9dicas","article_modified_time":"2026-06-05T14:26:18+00:00","og_image":[{"width":1920,"height":610,"url":"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2024\/05\/patrocinadores.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"26 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cimmdp.com.ar\/patrocinadores\/","url":"https:\/\/www.cimmdp.com.ar\/patrocinadores\/","name":"Sponsors - Centro de Investigaciones M\u00e9dicas","isPartOf":{"@id":"https:\/\/www.cimmdp.com.ar\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cimmdp.com.ar\/patrocinadores\/#primaryimage"},"image":{"@id":"https:\/\/www.cimmdp.com.ar\/patrocinadores\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2024\/05\/patrocinadores.jpg","datePublished":"2024-05-25T21:32:33+00:00","dateModified":"2026-06-05T14:26:18+00:00","description":"More than 120 studies with strict monitoring of Good Clinical Practices and a high degree of professionalism.","breadcrumb":{"@id":"https:\/\/www.cimmdp.com.ar\/patrocinadores\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cimmdp.com.ar\/patrocinadores\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cimmdp.com.ar\/patrocinadores\/#primaryimage","url":"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2024\/05\/patrocinadores.jpg","contentUrl":"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2024\/05\/patrocinadores.jpg","width":1920,"height":610},{"@type":"BreadcrumbList","@id":"https:\/\/www.cimmdp.com.ar\/patrocinadores\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/www.cimmdp.com.ar\/"},{"@type":"ListItem","position":2,"name":"Patrocinadores"}]},{"@type":"WebSite","@id":"https:\/\/www.cimmdp.com.ar\/#website","url":"https:\/\/www.cimmdp.com.ar\/","name":"Centro de Investigaciones M\u00e9dicas","description":"Highly qualified medical team with extensive experience in Clinical Research","publisher":{"@id":"https:\/\/www.cimmdp.com.ar\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cimmdp.com.ar\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.cimmdp.com.ar\/#organization","name":"Centro de Investigaciones M\u00e9dicas","url":"https:\/\/www.cimmdp.com.ar\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cimmdp.com.ar\/#\/schema\/logo\/image\/","url":"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2020\/07\/centro-de-investigaciones-medicas-mdp-logo.png","contentUrl":"https:\/\/www.cimmdp.com.ar\/wp-content\/uploads\/2020\/07\/centro-de-investigaciones-medicas-mdp-logo.png","width":235,"height":70,"caption":"Centro de Investigaciones M\u00e9dicas"},"image":{"@id":"https:\/\/www.cimmdp.com.ar\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cimmdp.com.ar\/en\/wp-json\/wp\/v2\/pages\/1917","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cimmdp.com.ar\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.cimmdp.com.ar\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.cimmdp.com.ar\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cimmdp.com.ar\/en\/wp-json\/wp\/v2\/comments?post=1917"}],"version-history":[{"count":17,"href":"https:\/\/www.cimmdp.com.ar\/en\/wp-json\/wp\/v2\/pages\/1917\/revisions"}],"predecessor-version":[{"id":3229,"href":"https:\/\/www.cimmdp.com.ar\/en\/wp-json\/wp\/v2\/pages\/1917\/revisions\/3229"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cimmdp.com.ar\/en\/wp-json\/wp\/v2\/media\/1998"}],"wp:attachment":[{"href":"https:\/\/www.cimmdp.com.ar\/en\/wp-json\/wp\/v2\/media?parent=1917"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}